New Blood Pressure Monitor Boasts ECG Capability
|
By HospiMedica International staff writers Posted on 22 Apr 2019 |

Image: The Omron Complete combine BP and AF monitoring (Photo courtesy of Omron Healthcare).
A groundbreaking monitor intended for home use combines blood pressure (BP) and electrocardiogram (ECG) readings in a single device.
The Omron Healthcare (Kyoto, Japan) Complete (HEM-7530T) is an upper arm BP monitor that allows users to simultaneously take a three-lead ECG reading by merely touching electrodes conveniently located on the top face and both side surfaces of the monitor. The Complete device was developed in partnership with AliveCor (San Francisco, CA, USA), and uses a new, advanced algorithm specifically designed for improved detection of the possibility of atrial fibrillation (AF).
After an ECG scan, Omron Complete will notify the user if AF has been detected. Using the smartphone Omron Connect App, the readings can then be stored, tracked, and shared with doctors, family and caregivers to provide deeper heart health insights. An easy-to-navigate, user-friendly interface that features an intuitive dashboard conveniently charts and graphs the data--making it viewable by day, week, month, or year--making it easy for users to keep close watch on heart health trends.
“Millions of Americans are living with atrial fibrillation and a stroke risk that is five times higher than average, and many others may not know they have this condition since it is difficult to diagnose,” said Randy Kellogg, president and CEO of Omron Healthcare. “Monitoring this condition and the risk it carries is part of our ‘Going for Zero’ mission. That's why Omron developed Complete as an accessible, easy-to-use, at-home solution to provide a more complete heart health picture and greater peace of mind.”
AF occurs when the heart's two upper chambers beat erratically. In one form, paroxysmal AF, patients have bouts of erratic beats that begin spontaneously and usually last less than a week. It can lead to serious adverse events such as thrombi traveling from the heart to obstruct arteries supplying the brain, causing stroke, or other parts of the body causing tissue damage.
The Omron Healthcare (Kyoto, Japan) Complete (HEM-7530T) is an upper arm BP monitor that allows users to simultaneously take a three-lead ECG reading by merely touching electrodes conveniently located on the top face and both side surfaces of the monitor. The Complete device was developed in partnership with AliveCor (San Francisco, CA, USA), and uses a new, advanced algorithm specifically designed for improved detection of the possibility of atrial fibrillation (AF).
After an ECG scan, Omron Complete will notify the user if AF has been detected. Using the smartphone Omron Connect App, the readings can then be stored, tracked, and shared with doctors, family and caregivers to provide deeper heart health insights. An easy-to-navigate, user-friendly interface that features an intuitive dashboard conveniently charts and graphs the data--making it viewable by day, week, month, or year--making it easy for users to keep close watch on heart health trends.
“Millions of Americans are living with atrial fibrillation and a stroke risk that is five times higher than average, and many others may not know they have this condition since it is difficult to diagnose,” said Randy Kellogg, president and CEO of Omron Healthcare. “Monitoring this condition and the risk it carries is part of our ‘Going for Zero’ mission. That's why Omron developed Complete as an accessible, easy-to-use, at-home solution to provide a more complete heart health picture and greater peace of mind.”
AF occurs when the heart's two upper chambers beat erratically. In one form, paroxysmal AF, patients have bouts of erratic beats that begin spontaneously and usually last less than a week. It can lead to serious adverse events such as thrombi traveling from the heart to obstruct arteries supplying the brain, causing stroke, or other parts of the body causing tissue damage.
Latest Critical Care News
- Nanohydrogels Guide Medicine to Tumors Without Damaging Healthy Tissue
- Magnetic Gel Offers Safer and More Effective Atrial Fibrillation Treatment
- Hydrogel Biosensor Detects and Differentiates Blood Circulation Complications
- Spray-Type Technology Coats Transplant Organs with Immunosuppressants to Prevent Rejection
- Single Heart Attack Shot to Revolutionize Cardiac Care
- Machine-Learning Model Predicts Preeclampsia in Late Pregnancy
- Single Mid-Wave Infrared Thermal Camera Enables Noncontact Vital Signs Monitoring
- 3D-Printed Bandage to Help Heal Chronic Wounds
- Ultrasound-Activated Nanoagents Kill Superbugs Hiding in Biofilms
- Painless Microneedle Skin Patch Monitors Immune Health

- Smart T-Shirt Uses AI to Enhance Detection of Heart Rhythm Disorders
- Aptamers Enable Real-Time Biomarker Tracking Without Blood Draws
- Specialized Dressing with Sensor Monitors pH Levels in Chronic Wounds
- AI Model Could Help Diagnose Spinal Cord Disease Up To 30 Months Earlier
- 3D-Printed Swallowable Robot Could Perform Gastrointestinal Procedures
- Next-Gen Hydrogel Could Transform Soft Tissue and Organ Repair
Channels
Artificial Intelligence
view channel
AI Model Identifies Rare Endocrine Disorder from Hand Images
Acromegaly is a rare, intractable disease that typically begins in middle age and causes enlargement of the hands and feet, changes in facial appearance, and abnormal bone and organ growth.... Read moreSurgical Techniques
view channel
Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
Tumors located in the caudate lobe of the liver present a major surgical challenge. This deep section of the liver sits close to critical blood vessels, making traditional surgical access difficult and... Read more
Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
Successful cancer surgery relies on a surgeon’s ability to remove tumors while preserving as much healthy tissue as possible. To assist with this, surgeons often use fluorescent dyes that cause cancer... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
Quantum Surgical Acquires NeuWave from Johnson & Johnson
Quantum Surgical announced that it has acquired NeuWave Medical from Johnson & Johnson. NeuWave’s microwave ablation system is used in percutaneous tumor ablation procedures, and the acquisition supports... Read more
Medtronic to Acquire Coronary Artery Medtech Company CathWorks
Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more







